Recap: Karyopharm Therapeutics Q1 Earnings

Karyopharm Therapeutics KPTI reported its Q1 earnings results on Thursday, May 4, 2023 at 07:45 AM.

Here's what investors need to know about the announcement.

Karyopharm Therapeutics beat estimated earnings by 18.92%, reporting an EPS of $-0.3 versus an estimate of $-0.37.

Revenue was down $8.97 million from the same period last year.

Last quarter the company missed on EPS by $0.08 which was followed by a 1.91% drop in the share price the next day.

Here's a look at Karyopharm Therapeutics's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-0.35	-0.57	-0.63	-0.63
EPS Actual	-0.43	-0.45	-0.62	-0.53
Revenue Estimate	35.12M	34.56M	35.59M	34.17M
Revenue Actual	33.58M	36.15M	39.68M	47.67M

To track all earnings releases for Karyopharm Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar